1. Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. Issue 9 (29th July 2022) Authors: Kuo, Alyce M.; Hassoun, Hani; Shah, Urvi; Gordon, Allison; Hollmann, Travis J.; Landau, Heather J.; Lezcano, Cecilia; Mailankody, Sham; Tan, Carlyn C.; Lesokhin, Alexander M.; Markova, Alina Journal: Leukemia & lymphoma Issue: Volume 63:Issue 9(2022) Page Start: 2233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗